Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
san francisco top stories
sanofi
5
×
biotech
clinical trials
national top stories
cancer
deals
new york blog main
new york top stories
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
ipo
national
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
roche
san diego blog main
san diego top stories
san francisco
seattle blog main
seattle top stories
texas blog main
texas top stories
the column group
third rock ventures
What
cancer
5
×
medicines
ahead
bio
days
drug
ipo
pharmaceutical
proteins
reach
research
revolution
roundup
abbvie’s
ambien
american
annual
asco
attendees
attention
bets
biofourmis
biotech
bucks
camp’s
cancer’s
cash
celebrate
chance
chicago
city
clinical
combinations
comes
community’s
companies
corner
cut
date
day
Language
unset
Current search:
sanofi
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
